Endocrinology, Vol 137, 1042-1048, Copyright © 1996 by Endocrine Society

ARTICLES

Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts

S Wada, N Udagawa, N Nagata, TJ Martin and DM Findlay
St. Vincent's Institute of Medical Research, Melbourne, Australia.

We have reported that short calcitonin (CT) treatment of mature mouse osteoclast-like cells (OCLs) in culture induced prolonged down- regulation of the CT receptor (CTR) and desensitization to CT rechallenge, at the level of adenylate cyclase activity. In this study, we have extended those studies to examine the bone resorbing activity of OCLs pretreated with CT. OCLs, which formed on gelled type I collagen, were pretreated with salmon CT (sCT)(10(-9)M, 1 h) and 24 h later were replated onto plastic dishes or dentine slices after removal from the gel by collagenase digestion. The number and population of either mononuclear or multinuclear OCLs that adhere to either surface was not affected by sCT pretreatment. It was found that OCLs pretreated with sCT regained reduced but significant bone resorbing capacity, which was quantitated as the surface area resorbed by OCLs on dentine slices. However, compared with control, the number of resorption pits produced by sCT- pretreated OCLs was slightly reduced, and the total pit area was decreased by approximately 40-50%. The distribution of individual pit sizes was altered by sCT-pretreatment so that the number of larger pits was predominantly reduced, suggesting that short sCT treatment may produce a long lasting decrease in osteoclast mobility. sCT was able to inhibit bone resorption activity of CT-pretreated OCLs (ED50:10(-13)-10(-12)M). Importantly, the ED50 of sCT inhibition of bone resorption in sCT-pretreated OCLs was approximately 100-fold greater than for control, indicating resistance of the OCLs to CT rechallenge. Consistent with these results, treatment of OCLs with sCT greatly decreased the expression of CTR messenger RNA, whereas no significant effect was observed on the tartrate-resistant acid phosphatase messenger RNA expression, a marker of resorptive capacity of osteoclasts. These results indicate, therefore, that an important component of escape of osteoclastic resorption from CT inhibition is CT resistance of mature osteoclasts, which regain bone resorbing function.

This article has been cited by other articles:

				Ph. Lesclous, F. Schramm, S. Gallina, B. Baroukh, D. Guez, and J. L. Saffar Histamine mediates osteoclastic resorption only during the acute phase of bone loss in ovariectomized rats Exp Physiol, May 1, 2006; 91(3): 561 - 570. [Abstract] [Full Text] [PDF]

				A. Samura, S. Wada, S. Suda, M. Iitaka, and S. Katayama Calcitonin Receptor Regulation and Responsiveness to Calcitonin in Human Osteoclast-Like Cells Prepared in Vitro using Receptor Activator of Nuclear Factor-{kappa}B Ligand and Macrophage Colony-Stimulating Factor Endocrinology, October 1, 2000; 141(10): 3774 - 3782. [Abstract] [Full Text] [PDF]

				D. Inoue, C. Shih, D. L. Galson, S. R. Goldring, W. C. Horne, and R. Baron Calcitonin-Dependent Down-Regulation of the Mouse C1a Calcitonin Receptor in Cells of the Osteoclast Lineage Involves a Transcriptional Mechanism Endocrinology, March 1, 1999; 140(3): 1060 - 1068. [Abstract] [Full Text]

				S. Wada, N. Udagawa, T. Akatsu, N. Nagata, T. J. Martin, and D. M. Findlay Regulation by Calcitonin and Glucocorticoids of Calcitonin Receptor Gene Expression in Mouse Osteoclasts Endocrinology, February 1, 1997; 138(2): 521 - 529. [Abstract] [Full Text] [PDF]

				K. Horie and P. A. Insel Retrovirally Mediated Transfer of a G Protein-coupled Receptor Kinase (GRK) Dominant-negative Mutant Enhances Endogenous Calcitonin Receptor Signaling in Chinese Hamster Ovary Cells. GRK INHIBITION ENHANCES EXPRESSION OF RECEPTORS AND RECEPTOR mRNA J. Biol. Chem., September 15, 2000; 275(38): 29433 - 29440. [Abstract] [Full Text] [PDF]